Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Nets Former Pharmacia Counsel Kingma To Support New Strategy

This article was originally published in The Tan Sheet

Executive Summary

Perrigo's appointment of former Pharmacia associate general counsel Todd Kingma to VP and general counsel reflects the firm's recent expansion into generic Rx pharmaceuticals and bolsters its OTC patent defense team
Advertisement

Related Content

Loratadine Sales Keep Perrigo On Track To Meet Core Business Growth Goals
Loratadine Sales Keep Perrigo On Track To Meet Core Business Growth Goals
Loratadine Sales Keep Perrigo On Track To Meet Core Business Growth Goals
Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales
Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales
Perrigo To Enter Generic Rx Drug Market With OTC Experience In Mind
Perrigo To Enter Generic Rx Drug Market With OTC Experience In Mind
Perrigo To Pay Attorney Fees In Imodium Trial; McNeil Patents Still “Obvious”
Perrigo New Products Include Branded Weight-Loss Supplement, Kid’s Multi
Perrigo’s Loratadine 505(b)(2) NDA Was Properly Submitted, Firm Maintains

Topics

Advertisement
UsernamePublicRestriction

Register

PS095906

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel